Articles by Susan J. Schniepp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan J. Schniepp

Managing Change Control in a Changing Environment

We never thought implementing complex changes could become more cumbersome.
Feb 2, 2010

We never thought implementing complex changes could become more cumbersome.

Insider Solutions: A New Direction for USP?

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.
Nov 2, 2009

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.

Insider Solutions: Preventing the Next Heparin Scare

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.
Aug 2, 2009

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.

Insider Solutions: Device Database Can Help Pharma

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.
Apr 2, 2009

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.

An Analytical Technique with Special Resonance

A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.
Feb 2, 2009

A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.

Insider Solutions: Have a Say in USP Standards

The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.
Jan 2, 2009

The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.

Risk Management within the Global Supply Chain

The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.
Oct 1, 2008

The growth and globalization of the pharmaceutical supply chain make risk assessment more important than ever for pharmaceutical manufacturers. The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.

Help Your Contract Laboratory Help You

Providing the right information upfront may ease new requirements to assess solvent levels.
Aug 6, 2008

Providing the right information upfront may ease new requirements to assess solvent levels.

Help Your Contract Laboratory Help You

Providing the right information upfront may ease new requirements to assess solvent levels.
Jul 2, 2008

Providing the right information upfront may ease new requirements to assess solvent levels.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here